sabato, 25 maggio 2024
11 Maggio 2018

Two years of PRIME. Driving innovation to where it is most needed

May 8, 2018 – In the two years since its launch, the PRIority Medicines scheme (PRIME) of the European Medicines Agency (EMA) has succeeded in driving innovation and improved the efficiency of the development process in therapeutic areas with the most pressing unmet medical needs. The goal is to support and optimise medicine development, so that patients whose diseases cannot be treated or who need better treatment options have access to new medicines that enable … (leggi tutto)